Two Democrats, Analilia Mejia and Tom Malinowski, were leading in a race for their party’s nomination to replace Gov. Mikie ...
After up to three years on GA Depot, most people with PPMS have not experienced any disability progression, according to new ...
Eleven candidates are running in a special primary election on Thursday to fill Gov. Mikie Sherrill’s former seat. They include a former member of Congress and the former lieutenant governor.
GA Depot is a long-acting injection version of the approved Glatiramer Acetate (GA, commercially available as Copaxone ® /Glatopa ® ). PPMS is characterized by continued worsening neurologic function ...
Specialists in multiple sclerosis will gather in San Diego for ACTRIMS Forum 2026, Feb. 5-7, where the theme will be “MS at a ...
South Wales Argus on MSN
Man told he'd be in a wheelchair in five years defies odds with fitness win
Louis Davies, a Welsh mental health worker with MS, defies odds to win London Hyrox adaptive fitness title.
AB Science SA (Euronext - FR0010557264 - AB) today announced that the Japanese Patent Office has formally granted a patent for methods of treating progressive multiple sclerosis (MS) with its lead ...
AB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL 2041 THIS IS THE FIRST COUNTRY DELIVERING THE MS PATENT MASITINIB HAS ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Fatigue is one of the most common and challenging symptoms for people living with primary-progressive and secondary-progressive multiple sclerosis (MS). It affects physical stamina, mental clarity, ...
Findings showed treatment with tolebrutinib did not significantly delay disability progression compared with placebo. A phase 3 study evaluating tolebrutinib for the treatment of primary progressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results